Gene expression: protein interaction systems network modeling identifies transformation-associated molecules and

Sharmila A Bapat1, Anagha Krishnan, Avinash D Ghanate

  • 1National Centre for Cell Science, NCCS Complex and Institute of Bioinformatics & Biotechnology, Pune University, Pune, India. sabapat@nccs.res.in

Cancer Research
|June 10, 2010
PubMed

Insights

Genetic defects cause ovarian cancer heterogeneity. This study identifies interconnected gene modules and pathways, including c-Myc and p53, crucial for tumor development and potentially guiding personalized therapies.

Area of Science:

  • Genomics
  • Systems Biology
  • Oncology

Background:

  • Tumor heterogeneity arises from diverse genetic defects, complicating treatment strategies.
  • Molecular mechanisms underlying cancer heterogeneity remain largely unknown.
  • Serous ovarian carcinoma exhibits significant phenotypic and therapeutic variability.

Purpose of the Study:

  • To elucidate the systems-level molecular mechanisms driving serous ovarian carcinoma heterogeneity.
  • To identify key gene modules and pathways involved in tumor development.
  • To discover novel predictive biomarkers for personalized therapeutic strategies.

Main Methods:

  • Analysis of three independent gene expression datasets from ovarian tumors.
  • Application of network prediction algorithms and protein interaction networks.
  • Validation of copy number alterations and epigenetic regulation impacts on gene expression.

Main Results:

  • Identification of interconnected gene modules associated with serous ovarian carcinoma.
  • Discovery of novel predictive biomarkers based on gene interconnectivity.
  • Validation of copy number alterations and epigenetic modifications influencing gene expression.
  • Pinpointing three key functional modules: c-Myc activation, retinoblastoma signaling, and p53/cell cycle/DNA damage repair pathways.

Conclusions:

  • Interconnected gene networks and functional modules are central to ovarian cancer development.
  • These findings highlight potential for developing specific biomarkers for personalized medicine.
  • Understanding gene-hub interactions can inform tailored therapeutic decisions for ovarian cancer patients.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
What is Gene Expression?01:36

What is Gene Expression?

A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then processed and...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...